They are testing dosage levels in Phase 2. Also, how do you imagine they can measure efficacy or safety with reduced dosage levels??... I suspect the participants were given a very small dose, so that even if there were a regeneration of hair cells, it was very few, and it would not be clear to the participant or a hearing test that an increase in hearing capability occurred.